Practice Test Geeks(CLIA) Clinical Laboratory Improvement Amendments Certification Practice Test
← All CLIA Flashcard Decks

Testing Procedures & Method Validation Flashcards

7 cards from real CLIA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Testing Procedures & Method Validation flashcards as text

  1. Which statistical measure is used to assess the systematic error (bias) of a new method compared to a reference method during method validation?

    Answer: Inaccuracy

    Inaccuracy measures systematic error (bias) — the difference between the new method's mean result and the true or reference value.

  2. Under CLIA, when must a laboratory re-validate a test method?

    Answer: When there is a significant change in reagents, equipment, or methodology

    CLIA requires re-verification or re-validation whenever a significant change occurs in reagent lots, equipment, or the testing process itself.

  3. The Westgard 1₃s rule is violated when:

    Answer: One control value exceeds ±3 SD

    The 1₃s rule is a warning/rejection rule triggered when a single control result falls outside ±3 standard deviations of the mean.

  4. What is the primary purpose of performing a linearity study during method validation?

    Answer: To confirm the method produces accurate results across its reportable range

    A linearity study verifies that the method produces results proportional to analyte concentration across the claimed analytical measurement range.

  5. A laboratory introduces a new whole blood glucose analyzer. According to CLIA, what is the minimum number of patient samples required for a comparison-of-methods experiment?

    Answer: 40

    CLIA guidance (and CLSI EP09) recommends a minimum of 40 patient samples spanning the analytical range for a method comparison study.

  6. Which interferent category encompasses endogenous substances such as bilirubin, hemoglobin, and lipids that may affect test results?

    Answer: Endogenous interferents

    Endogenous interferents are substances naturally present in the specimen that can falsely elevate or suppress analyte measurements.

  7. When verifying the reference interval for a non-waived quantitative test, CLIA guidelines suggest using a minimum of how many healthy reference subjects?

    Answer: 20

    CLIA and CLSI recommend verifying a manufacturer's reference interval with at least 20 healthy reference individuals.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. cms.gov — Eligibility, renewal, score validity, fees · verified Oct 2026